PUBLICATIONS - Report on the European Market for Neurodiagnostic Products:
This article was originally published in Clinica
Executive Summary
International marketing consultancy Frost & Sullivan has published a report on The European Market for Neurodiagnostic Products. It looks at the different sectors within the market and discusses future growth. The report also gives a detailed account of the trends emerging from the market, as manufacturers attempt to find ways of increasing their end-user base and to meet the demands for clinical and cost-effective care in Europe's healthcare market. For more information contact Frost & Sullivan's UK office. Tel: +44 171 915 7824. Fax: +44 171 730 3343.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.